CD34 and graft versus host disease: Deaths related to infectious complication were significantly more frequent in the CD34+ group (16/28 versus 19/53 in ATG group, p = 0.045), while there was no difference between groups regarding death related to GVHD (5/28 in CD34+ versus 14/53 in ATG group, p = 0.41).